Fri, 20 Jul 2018 19:37:51: Insilico and A2A launch new Duchenne-focused AI drug company

Fri, 20 Jul 2018 10:11:57: PTC inks $200M Agilis takeover to snag late-phase gene therapy

Fri, 20 Jul 2018 09:38:59: Patient death prompts FDA hold on Mersana’s lead cancer ADC

Fri, 20 Jul 2018 09:25:49: Roche, PureTech team up to develop oral antisense oligonucleotides

Thu, 19 Jul 2018 19:41:14: Chutes & Ladders—Human Longevity CFO/COO departs after scandal

Thu, 19 Jul 2018 15:13:26: An eye drop for macular degeneration shows promise in animal studies

Thu, 19 Jul 2018 13:43:09: Hospital infection immunotherapy developer Aridis files for $34.5M IPO

Thu, 19 Jul 2018 12:17:24: Stripped-down Vical ‘considering options’ after pipeline woes

Thu, 19 Jul 2018 11:09:34: Novartis pays €95M to bag dermatitis drug from Galapagos, MorphoSys

Thu, 19 Jul 2018 10:37:32: Gilead’s Kite bags option to buy gamma delta startup Gadeta

Thu, 19 Jul 2018 08:45:38: Could a chili pepper derivative used for pain also help fight obesity?

Wed, 18 Jul 2018 17:36:57: Johns Hopkins startup Neuraly plans phase 1 Parkinson’s trial with $36M round

Wed, 18 Jul 2018 14:00:50: Bill Gates and others launch $30M ‘venture philanthropy’ accelerator for Alzheimer’s diagnostics

Wed, 18 Jul 2018 13:16:23: Pfizer and Lilly claim win for NGF pain drug in osteoarthritis

Wed, 18 Jul 2018 11:51:47: U.K. votes to ‘fully participate’ in EMA after Brexit

Wed, 18 Jul 2018 11:08:44: Sanofi bags rights to Revolution’s SHP2 cancer drug

Tue, 17 Jul 2018 13:33:34: Nimbus veterans launch allosteric drugmaker HotSpot Therapeutics with $45M series A

Tue, 17 Jul 2018 13:07:14: Ascentage third round garners $150M for apoptosis cancer drugs

Tue, 17 Jul 2018 11:48:14: Latest CRISPR therapy concern weighs on share prices

Tue, 17 Jul 2018 11:48:02: In a first, FDA approves SIGA’s smallpox treatment

Tue, 17 Jul 2018 09:31:08: Celgene, Takeda invest in intratumoral microdosing firm Presage

Mon, 16 Jul 2018 18:50:40: Spero nets $54M biodefense R&D contract for its lead antibiotic

Mon, 16 Jul 2018 14:04:05: Could even more cancer patients benefit from PARP inhibitors?

Mon, 16 Jul 2018 12:37:51: FDA AdComm backs GlaxoSmithKline’s 1-shot P. vivax malaria therapy

Mon, 16 Jul 2018 08:42:23: Pliant Therapeutics closes $62M round, eyeing fibrotic disease work